“My career is focused on doing research on and taking care of patients with metabolic bone diseases. I have benefitted greatly from my involvement with the ASBMR. The society connects me with other leaders in the field and I am honored to take on the role of president for the coming year,” said Dr. Econs. “I look forward to continuing this growth with my colleagues in leading our organization and advancing the field of bone, mineral and musculoskeletal research.”
Dr. Econs’ general interest is in the genetic aspects of metabolic bone diseases. He played important roles in the discovery of the genes responsible X-linked hypophosphatemic rickets (PHEX), autosomal dominant hypophosphatemic rickets (FGF23), autosomal dominate osteopetrosis (CLCN7), and osteoglophonic dysplasia (FDFR1). His clinical interests are in the field of metabolic bone diseases, including gosteomalacias, osteoporosis, Paget’s disease, hyperparathyroidism and hypoparathyroidism.
In addition to serving on the ASBMR Council as president-elect this past year, Dr. Econs has served as both the chair of the Ethic Advisory Committee and as an ASBMR councilor. He will assume the role as president until September 2018.
The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.
IU School of Medicine
With more than 60 academic departments and specialty divisions across nine campuses and strong clinical partnerships with Indiana’s most advanced hospitals and physician networks, Indiana University School of Medicine is continuously advancing its mission to prepare healers and transform health in Indiana and throughout the world.